E-DRUG: Medicines Transparency and Good Governance in Jordan
------------------------------------------------------------
[E-druggers in Geneva next week are invited to this meeting where one of
the seven pilot countries of MeTA is talking about its first year of
activities. MeTA Jordan and MeTA International staff will be attending.
MeTA Jordan page:
http://www.medicinestransparency.org/meta-countries/jordan/
Read also the WHO/GGM paper on transparency in Jordan, see:
http://www.who.int/medicines/areas/policy/goodgovernance/MeasuringTransp
arencyJordan.pdf
WHO/GGM programme in general:
http://www.who.int/medicines/ggm/en/index.html
WB]
Medicines Transparency and Good Governance in Jordan
Briefing for Delegates to the 62nd World Health Assembly
Tuesday, 19 May 2009 from 13.00-14.30
Palais des Nations, Geneva
Room IX
Light refreshments will be available.
The Ministry of Health of Jordan invites delegates to the 62nd WHA to
hear how two programmes aimed at improving access to essential medicines
are making a difference.
Both the Medicines Transparency Alliance (MeTA) and the Good Governance
for Medicines (GGM) programmes are working in Jordan, helping to improve
transparency and accountability in the medicines sector.
The presentations will include briefings on the global MeTA and GGM
programmes, lessons learned from pilot countries and how both programmes
are working in Jordan, followed by a panel discussion, involving
government, business and civil society representatives as well as WHO
and MeTA officials.
Programme for the briefing:
Chair Dr Hashim El Zein Mousaad (WHO Representative, Jordan)
. Welcome - His Excellency Minister of Health for Jordan, Dr Nayef Al
Fayez
. Opening Remarks - Dr Hans Hogerzeil, Director Essential Medicines and
Pharmaceutical Policies (EMP), WHO Geneva
. Medicines Transparency Alliance (MeTA) Overview and lessons learned in
pilot countries - Brian Elliott, International MeTA Secretariat
. Good Governance for Medicines Programme (GGM) - Dr Guitelle Baghdadi,
WHO Geneva
. MeTA in Jordan - Dr Taher Al Samen, Chairman MeTA Council
. GGM in Jordan - Dr Mohammad Rawashdeh, Director General, JFDA
. Q&A - panel discussion
Please contact Andrew Chetley (achetley@metasecretariat.org) to indicate
your intention to attend this briefing.
For more information please see www.MedicinesTransparency.org and
http://www.who.int/medicines/ggm/en/